Aurora Spine Corporation

ASG.VTSXVHealthcare● Active

$0.23

+$0.00(+0.00%)

Market Cap$17961206

P/E Ratio—

52W High$0.355

52W Low$0.205

Avg Volume41K

Open$0.22

Beta-0.54

Free Cash Flow Financials Revenue

Aurora Spine Corporation (ASG.V) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ASG.V · free cash flow · updated Jun 9, 2026

Core FCF metrics

ASG.V · FCF · TTM · margin & CAGR

Free cash flow was $419,974 for FY2025 (fiscal year ending 2025-12-31), up 57.6% year-over-year The FCF margin was 2.3%.

FY2025 Free Cash Flow$419,974▲ +57.6% YoY

Trailing 12M (TTM)$764,079trailing 4 quarters sum

FCF Margin2.3%$419,974 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ASG.V · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$933,423(1M)$419,974▲ +57.6%2.3%

FY2024$904,332(1M)$266,471▲ +118.8%1.5%

FY2023−$935,061(0M)−$1.4M▲ +41.8%-9.7%

FY2022−$1.6M(1M)−$2.4M▲ +14.7%-16.3%

FY2021−$2.1M(1M)−$2.8M▼ 1062.9%-27.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ASG.V · P/FCF · FCF yield · FCF per share

Aurora Spine Corporation (ASG.V) trades at a FCF yield of 5.94% and a price-to-free-cash-flow ratio of 23.0x. FCF per share stands at $0.01, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

5.94%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.01

TTM FCF ÷ Shares Outstanding

Price / FCF

x23.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x18.8

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

ASG.V · cash flow statement · operating / investing / financing

For FY2025, Aurora Spine Corporation generated $0.9M in operating cash flow and spent 1M in capital expenditures, yielding $0.4M in free cash flow.

Operating Activities

+$0.9M

Cash from core business operations

2025-12-31

Investing Activities

−$0.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$0.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($0.9M) − |CapEx| (1M) = FCF ($0.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ASG.V vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Aurora Spine CorporationYOU

ASG.V

$419,974+57.6%2.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Aurora Spine Corporation (ASG.V) reported free cash flow of $419,974 for FY2025 (fiscal year ending 2025-12-31), up 57.6% year-over-year. The FCF margin was 2.3%.

Based on available data, Aurora Spine Corporation has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $419,974 in FY2025.

Aurora Spine Corporation's FCF yield is 5.94% and price-to-FCF ratio is 23.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ASG.V free cash flow · 8 questions

Aurora Spine Corporation free cash flow was $419,974 for FY2025, up 57.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $764,079.

ASG.V free cash flowASG.V FCFASG.V FCF 2025ASG.V free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Aurora Spine Corporation · Aurora Spine Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026